Expression of Bcl-2 and Bcl-2-Ig fusion transcripts in normal and neoplastic cells.

W B Graninger; M Seto; B Boutain; P Goldman; S J Korsmeyer

doi:10.1172/JCI113235

Department of Medicine, Microbiology and Immunology, Howard Hughes Medical Institute, Washington University School of Medicine, St. Louis, Missouri 63110.

Find articles by Graninger, W. in: PubMed | Google Scholar

Department of Medicine, Microbiology and Immunology, Howard Hughes Medical Institute, Washington University School of Medicine, St. Louis, Missouri 63110.

Find articles by Seto, M. in: PubMed | Google Scholar

Department of Medicine, Microbiology and Immunology, Howard Hughes Medical Institute, Washington University School of Medicine, St. Louis, Missouri 63110.

Find articles by Boutain, B. in: PubMed | Google Scholar

Department of Medicine, Microbiology and Immunology, Howard Hughes Medical Institute, Washington University School of Medicine, St. Louis, Missouri 63110.

Find articles by Goldman, P. in: PubMed | Google Scholar

Department of Medicine, Microbiology and Immunology, Howard Hughes Medical Institute, Washington University School of Medicine, St. Louis, Missouri 63110.

Find articles by Korsmeyer, S. in: PubMed | Google Scholar

Published in Volume 80, Issue 5 on November 1, 1987
J Clin Invest. 1987;80(5):1512–1515. https://doi.org/10.1172/JCI113235.
© 1987 The American Society for Clinical Investigation

Published November 1, 1987 - Version history

We examined the expression of the Bcl-2 gene at chromosome segment 18q21, that is translocated into the Ig heavy chain gene locus in t(14;18) bearing lymphomas. Bcl-2, while B cell associated, is expressed in a variety of hematopoietic lineages including T cells. Bcl-2 mRNA levels are high during pre-B cell development, the time at which the t(14;18) translocation occurs, but are down regulated with maturation. Like certain other oncogenes, Bcl-2 is quiescent in resting B cells but up-regulated with B cell activation. Mature B cell lymphomas with a t(14;18) have log-folds more mRNA than matched counterparts without the translocation. A sensitive S1 protection assay revealed that all transcripts in t(14;18) B cells were Bcl-2-Ig fusion mRNAs and originated from the translocated allele. Thus, there is a marked deregulation of Bcl-2 when it is introduced into the Ig locus in t(14;18) lymphomas.

Images.

Click on an image below to see the page. View PDF of the complete article